chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 1 - Extreme Lethargy  Day 2 - Sore arm, weakness, dizziness, lethargy, and unknown pressure in top left side of brain. Day 3 - Headache, Sore arm, weakness, dizziness, lethargy, and unknown pressure in my head. Day 4 - 101 degree fever, headache, sore arm, weakness, dizziness, lethargy and unknown pressure in my head.  Day 5-7 -  Headache, dizziness, weakness, lethargy and unknown pressure in my head.
dizziness, floating, shivering in legs.  Vitals all with-in normal limits..juice given, rested in office for 1hr 15 min post injection
Facial swelling, rash on face, swollen eyes, burning, itchy, tight feeling, eyes burning
extreme soreness in left arm, exhaustion, dizziness, headache, nausea  The left arm was sore immediately along with left bicep pain, the dizziness and nausea followed approximately 30 minutes post shot.  Cold chills through the night from about 11pm-6:30am the following day and continued pain and twitching in arm muscles.  Approximately 9am the next day, nausea and dizziness persisted and became worse. They are still persisting along with hot flashes at 22 hours post shot.
Seizure like activity to right side of body with elevated temp. Event lasted a few minutes. Body started to cool down and seizure like activity stopped.
Increasing swelling and redness with purple discoloration in the center (approximately 3 inches in diameter) to R thigh at site of DTaP vaccine.  Area of redness and swelling approximately 1-2 inches in diameter located on L upper arm at site of Varicella vaccine.
6 days after receiving influenza vaccine and ProQuad pt developed fever 101.7 and ataxia with frequent falling.
Day after vaccine patient developed fever, 2nd day lymphadenopathy, rash, strawberry tongue. Pneumonia/pneumonitis, cracking of lips 4th day, edematous of hands & feet. Acolic stools and then dilatation of coronary arteries - Kawasaki disease was diagnosed on 5th day of fever (6 day after vaccination).
This case was reported by a consumer via call center representative and described the occurrence of chills in a adult female patient who received SHINGRIX. On 3rd May 2018, the patient received the 1st dose of SHINGRIX. On 5th May 2018, 2 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site warmth and injection site swelling. In May 2018, the patient experienced chills, fever and influenza-like symptoms. In May 2018, the outcome of the chills was recovered/resolved. On an unknown date, the outcome of the injection site erythema, injection site warmth, injection site swelling, fever and influenza-like symptoms were recovered/resolved. The reporter considered the chills, injection site erythema, injection site warmth, injection site swelling and influenza-like symptoms to be related to SHINGRIX. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine on left arm at approximately 11:00 AM. The patient reported that she experienced a fever, chills and flu like symptoms that lasted a day or two after receiving the SHINGRIX vaccine. She also reported a hot, red and swollen area at the injection site that started two days later and stayed for one week. The patient had denied permission to contact their physician.
Started with sudden severe headache. Pain continued 2 days. Nausea started around 2pm, shortly after began vomiting. I vomited for 2 days, 2nd day was not as bad as first. Night one and night 2 I had horrible night sweats and leg cramps. IT WAS VERY SEVERE. 2nd day of headache, pain behind my right started. Upon waking on day 2, I felt pain in arm where shot was administered. Pain went down entire arm and across half of my chest. The pain felt like a huge bruise. Veins over the painful area were very noticeable and tender w/ red flat rash (lasted till 3rd day). Vision became cloudy day 5, swelling of joints and redness also started day 5-this vaccine no doubt put my disease in to an active state. I am beyond FURIOUS there is not more of an extensive questionnaire to determine if someone is healthy enough for a flu shot. Not anywhere does it ask if someone has an autoimmune disease! NOT ANYWHERE! Saw eye doctor day 7. Diagnosed with another bout of iritis in right eye (last iritis was 7 months prior). Eye doctor and pharmacist agree the timing is too close to be anything but a coincidence. I am waiting to get in to my rheumatologist. I have to use steroid drops every 2 hours for 2 days, them every 4 for 4 days. In 7 months my suspected open-angle glaucoma in my right eye has suddenly changed to closed-angle. NOT A LIKELY EVENT given that for over 10 years I had the very opposite and just 7 months prior it was still the opposite of what I have now.
I have severe menstrual problems. Excruciating cramps and heavy bleeding. It started the day after the jab. A lot of women been saying that they had reactions like this and it's not being study which is upsetting.
Arm got red, hurt and red rash on my arms, hands and legs, had aching, chills, hoarse, cough and was swollen around my vocal cord.
I had an extremely sore arm with fever and chills about 24 hours after receiving the vaccine. I started having numbness and pain in my left hand in 01/2023. Occasionally I will have the pain in my arm too. I am currently doing physical therapy to help with my symptoms. I found out I was pregnant on 09/14/2022.  My estimated due date is 05/22/2023. I had some morning sickness with fatigue in the first trimester. In second trimester is when the arm and hand numbness started.
unexpected increase in blood pressure.  Caused blood vessel in eye to rupture, partial lose of sight
Fever, lymphadenopathy, diffuse bullous rash, admitted to hospital, other diagnoses ruled out with lab studies and skin biopsy.
Information has been received through a pregnancy registry for varicella virus vaccine live from an RN concerning a 24 year old female who on 8/7/01 was vaccinated with varicella virus vaccine live, MMRII and tetanus toxoid. The pt received the same 3 vaccines again on 9/28/01. It was reported that the pt became pregnant probably within a week or two of receiving her 2nd doses of these vaccines. During the pt's 3rd month of pregnancy, her water broke and she had trouble with bleeding. At the time of this report, the pt is 7 months pregnant and has a due date of 7/4/02. It was reported that the pt is now doing fine. Unspecified medical attention was sought. Upon internal review, the events of hemorrhage and premature rupture of membranes were felt to be serious for an "Other Medical Event". Additional information has been requested. Follow up information has been received from a physician who indicated that the outcome of the pregnancy resulted in a liveborn normal infant. There were no congenital anomalies, no other complications or abnormalities. There were no complications during pregnancy, and labor/delivery. There were no diagnostic tests performed during the pregnancy, no infections or illnesses during the pregnancy, and no concurrent medical conditions. There was no infant adverse events. No further information is expected.
Became light headed right after injection.  Sat down and monitored by EMS onsite. No additional follow up required
Since the injections my son has been irritable, and very sleepy. He usually resists afternoon naps, but since the shots, he has been unusually sleepy and slept most afternoons without prodding. Today, he woke up saying he was tired and sleepy, which is unlike him.  He has also been clumsy and running into things and fighting unnecessarily with his older brother. His head feels warm, but he does not have a fever. He just seems lethargic.
pt went to clinic on 11MAR93 w/c/o sore lt deltoid area redness, hot to touch (large area upper lt deltoid area);
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult male patient received bnt162b2 (BNT162B2), on 25Apr2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes and a touch of heart disease" (unspecified if ongoing), notes: Diabetes and a touch of heart disease; "Diabetes and a touch of heart disease" (unspecified if ongoing), notes: Diabetes and a touch of heart disease; "known allergies: Sulfa drugs" (unspecified if ongoing), notes: known allergies: Sulfa drugs. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Paxlovid was taken as treatment for COVID-19 from 30Sep2023. The patient was taking other medication/products within 2 weeks of starting COVID-19 treatment and the patient previously received a COVID-19 vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
It started the next day with fatigue, headache and light headed. It only last for that day.
possible szs, high fever 102 in ER; febrile episode w/probable febrile seizures; mom said T was 100 @ one time-pt w/strep infect-pt given Amox;
On 9/29/11 pt. recvd PNEUMOVAX & seasonal flu high dose. At approx 9:00-10:00 pm same day pt. experienced burning eyes, secretions from eyes, dizzy, vomiting & chills. Also swelling in lips & dry mouth.
Shortly after administration (within 3 minutes) patient said he felt nauseous. Started sweating, felt clammy and said he felt like he may black out. Called 911. Got ice pack. Placed on back of neck. Ice water to drink. Talked with him to ER.
Systemic: Seizure-Severe, Additional Details: pt received vaccine and while in 15 minute waiting period went to front of store to make a purchase.  while at cash register he suffered a seizure, 911 called and responded within a few minutes.  Pt taken to hospital
The day after administration, 12/27, my right arm was in a lot of pain until  the morning of 12/29. The evening of 12/29 my right arm pit began to be tender.  The morning of 12/30, my right axilla was  mildly swollen but in pain. No redness. Today, 12/31, the swelling has gone down but my right axilla is still in  an uncomfortable amount of pain.
Redness that was spreading from injection site to armpit, pain with mobility, she described as hard muscle mass at site of injection that was spreading, she tried TYLENOL, ibuprofen, and cold compress with no relief and redness that continued to spread.
Patient was treated on 3/10/21 w/ 3 days of Bactrim for UTI. First COVID vaccine 3/18/21, that day developed redness and swelling of face, low back, chest, feet. Rash is persistent to this date with no imprvovement. She had bloodwork to rule out, RA, Lyme, thyroid disease all within normal limits. Skin biopsy was done 4/1/21 which showed likely hypersensitivity reaction to drug or ssytemic allergic versus a connective tissue disease.  Stains that were done argue against Lupus.
63 year old c/o allergies and animal dander, s/p head injury decreased memory, c/o itching x 2days (arms, back, legs) occurred after receiving vaccine, poor historian d/t decreased memory without rash, with red eyes Sx's resolved. Went to fair 10/5/2009 - ST occurred at that time saw ENT 10/9/09 thought Sx's D/T animal dander.
4/6/21 I awoke with symptoms of numbness/paralysis on left side of face limited to  upper lip and cheek area and both eyes would not stop watering. Movements to drink or make facial expressions were limited due to the numbness.  Because I have sensitive skin  I thought I may have had some type of reaction to something. So I waited to see if it would clear up through the day. I was not experiencing any other symptoms. By that evening it was apparent that I was not getting better and possibly getting worse because I began to experience some noticeable drooping in my cheek area. I decided to call my doctor in the morning. Because I am currently out of town, my home doctor suggested I see a local ER to rule out a stroke and determine if I was experiencing Bell's Palsy. I went to an ER clinic on 4/7/21
Pt devel h/a & dizziness shortly p/vax; By 5PM had red splotches & whelps w/itching over entire body; seen @ ER dx allergic rxn to vax;
severe achiness and shaking and fever to 104 F on 1/3/21. Unable to work for two days.  Question is - should I get the #2 dose in light of the robust antibody response to #1. Could it be even worse?? Any information on this?
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF RIGHT POPLITEAL VEIN 12/17/2022,  2/25/2023,  1/14/2023,  2/20/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
incomplete doses; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 7-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced incomplete dose administered. On an unknown date, the outcome of the incomplete dose administered was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received two incomplete doses of Influenza Vaccine Quadrivalent Unspecified Season when he was a new born, which led to incomplete dose administered. There was the reason why it were not full doses. The incomplete doses did not gave the patient an allergic reaction.  Then the patient received other Flu shot and had an allergic reaction and for the last 4 years the patient was vaccinated with Flulaval and had a reaction too, refer linked cases. This case is one of the 7 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR220135: US-GLAXOSMITHKLINE-US2021AMR220134: US-GLAXOSMITHKLINE-US2021AMR220133: US-GLAXOSMITHKLINE-US2021218250: US-GLAXOSMITHKLINE-US2021AMR220136: US-GLAXOSMITHKLINE-US2021AMR220131:
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. There was no information provided about the patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies. On 29-MAR-2017, the patient inadvertently received a dose of injectable PROQUAD (lot number reported as M01508 with expiration date on 09-APR-2018) for prophylaxis (strength, dose, frequency, route of administration and anatomical location were not reported) and injectable VARIVAX for prophylaxis (strength, dose, frequency, route of administration, anatomical location, lot # and expiration date were not reported). No adverse effects were reported. Additional information has been requested.
Diarrhea that afternoon, vomiting at 6:30 pm 10/08/12 and fussiness. Continued fussiness through today - 10/09/12.
This is in follow-up to report (s) previously submitted on 4/6/2007. Information has been received from a registered nurse concerning a 16 year old female with no pertinent medical history and no previous reactions who on 26, Feb 2007, at 3:15 p.m. was vaccinated with HPV rL1 06 11 16 18 VLP vaccine (yeast) first dose. Concomitant therapy included hepatitis A vaccine (inactive) (manufacturer unknown), diphtheria toxoid and tetanus toxoid all administered on the same day (26, Feb 2007). The nurse did not know if the vaccines were administered in the same arm as HPV rL1 6 11 16 18 VLP vaccine. On 26, Feb 2007, the patient developed swelling around both eyes and her face became red and itchy. The patient did not have a fever or any other symptoms. Unspecified medical attention was sought. On 04 Mar 2007, one week later, the patient recovered from swelling around both eyes and red and itchy face. Additional information has been requested. In follow-up it was reported that the patient came into the clinic, one week after the GARDASIL was given. She complained of swelling around both eyes, face itching and red. The patient denied any trouble breathing or trouble swallowing. The swelling and itching starte the day the vaccine was given, on 26-FEB-2007. When the client came into the clinic there was no swelling and no redness on exam. The patient was advised by the physician not to get the second dose of GARDASIL. It was reported that the patient recovered 1 week later. In follow-up the nurse reported that after the patient received her first dose of GARDASIL she developed swelling around both of her eyes and her face became red and itchy. The patient did not have a fever or any other symptoms. That same day, she was vaccinated with VAQTA (inactive) (manufacturer unknown), diphteria toxiod and tetanus toxoid. The nurse did not know if the vaccines were administered in the same arm. No further information is available. Additional information is not expected.
tested positive for covid after both doses; tested positive for covid after both doses; This is a spontaneous report from a contactable consumer. The report is from a facility regarding 3 residents at the facility who tested positive for COVID after receiving both doses of the vaccine. This is two of three reports. A 91-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: E10140 and Expiry date: 31Mar2021), via an unspecified route of administration on 13Jan2021 as single dose for COVID-19 immunization. Medical history included, cardiomegaly, acute kidney injury, atrial fibrillation, diabetes mellitus, hypertension, hyperlipidaemia and anaemia, all from an unknown date and unknown if ongoing. The historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: E10140 and Expiry date: 31Mar2021), via an unspecified route of administration on 23Dec2020 as single dose for COVID-19 immunization. There were no concomitant medications reported. On 30Mar2021 the patient tested positive for COVID after both doses. The patient underwent lab tests and procedures which included COVID-19 PCR test which was positive on 30Mar2021. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
pt recvd vax & 4 hrs later pt devel urticarial local rxn, erythema around DTP site 2.5 cm circular; lateral lth thigh w/4x2cm urticarial patch; warmth;
she had itching both ears and throat; she broke out in a rash, first on her left knee, then on her left leg, then on her right knee, now it's also on her back; This is a spontaneous report from a contactable consumer (patient herself). A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and lot number: EL9267) via an unspecified route of administration in left arm on 21Feb2021 14:30 as single dose for COVID-19 immunisation. Medical history included crps (Complex regional pain syndrome), svt- super ventricular and allergies to wheat. Concomitant medications included naproxen sodium (ALEVE). Patient previously took codeine and experienced with Allergies. On 21Feb2021 patient stated that she broke out in a rash, first on her left knee, then on her left leg, then on her right knee, now it's also on her back and a little on chest and arms. This morning on 23Feb2021 she had itching both ears and throat. Therapeutic measures were taken as a result of events and the patient took the treatment. The outcome of events was not recovered.  Information about lot/ batch number has been requested. Follow-up attempts are completed. No further information is expected.
1617 received the vaccine; 1633 began to c/o itching chest; seen by doctor; 1638 Benadryl 50mg IVP  1655 c/o less itching  1715 ok to leave
At about 2:20 PM , a bystander  in the post vaccine observation area noted that patient was becoming pale,  c/o throat felt like it was closing, felt dizzy,  and had a rash beginning on her upper chest. Bystander alerted medical personnel  and  the patient was eased to ground on a pad and placed in supine position. Oxygen at 3 L via NC started immediately. Initial B/P 145/82, P 80. She was administered 50 mg Benadryl orally at 2:28 pm  as her c/o sensation of throat closing was still present.  VS at 2:30 pm B/P 105/80.  VS  2:34 pm B/P 118/90.  She c/o occipital headache  8 out of 10 on pain scale at 2:47--VS B/P 120/78 P 68.  At 2:43 pm pulse oximetry 98% P 66.  3:15 pm Paramedics on scene and patient transported via ambulance to ER at Kaiser Hospital.
My daughter has get through infection; Sore throat; Runny nose; Fever; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the parent.  A 9 year-old female patient received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) at the age of 9 years as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INFECTION (non-serious) with onset 29Jan2022, outcome "unknown", described as "My daughter has get through infection"; OROPHARYNGEAL PAIN (non-serious) with onset 29Jan2022, outcome "unknown", described as "Sore throat"; RHINORRHOEA (non-serious) with onset 29Jan2022, outcome "unknown", described as "Runny nose"; PYREXIA (non-serious) with onset 29Jan2022, outcome "unknown", described as "Fever". Therapeutic measures were taken as a result of infection, oropharyngeal pain, rhinorrhoea, pyrexia.  Additional information: The patient received Tylenol (pediatric dose) as treatment of adverse event. The reporter stated bnt162b2 had causal relation with events.  The lot number for bnt162b2 was not provided and will be requested during follow up.
rash while eating in a restaurant; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash while eating in a restaurant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash while eating in a restaurant). At the time of the report, RASH (rash while eating in a restaurant) outcome was unknown.            Concomitant medications were not provided.  It was reported that patient had no symptoms after first and second doses.  Treatment information was not provided.
Right thigh became red around the injection site and continued to spread larger and became super hot to the touch. The evening of the 29th the rash took over her entire right thigh and was stinging. We went to the pediatrician the morning of the 30th and she was placed on an antibiotic because of the severness of the rash and the heat coming from it.